Fibromyalgia Clinical Trials

Find Fibromyalgia Clinical Trials Near You

Study of the Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Transcranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profile, and good efficacy in the contexts where it has been the subject of dedicated research: neuropathic pain, fibromyalgia, and visceral pain. Few studies have focused on the application of tDCS in the context of complex regional pain syndrome (CRPS), which is a common condition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Major

• Clinically active or active complex regional pain syndrome (CRPS) with positive Budapest criteria

• Scintigraphy showing signs consistent with CRPS

• Being affiliated with or a beneficiary of a social security scheme

Locations
Other Locations
France
Polyclinique de l'Europe
RECRUITING
Saint-nazaire
Contact Information
Primary
Valentin Billard
vbillard@vivalto-sante.com
02 51 16 16 16
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2027-06
Participants
Target number of participants: 32
Treatments
Experimental: Patient group receiving tDCS stimulation
Progressive increase in stimulation intensity up to 2 mA, then continuation at a plateau for a total of 20 minutes, then a decrease in stimulation intensity for 30 seconds at the end of the session before an automatic stop.
Placebo_comparator: Patient group receiving tDCS placebo stimulation
Control group : The stimulation intensity is gradually increased up to 2 mA for 1 minute, then decreased to zero stimulation. A further increase in stimulation is programmed 10 minutes after the start of stimulation.
Sponsors
Leads: Polyclinique de l'Europe

This content was sourced from clinicaltrials.gov